Hims Yields Ground in GLP-1 Market. Why Its CEO Is Calling It the Netflix of Pharma.
Hims & Hers Health will allow providers to prescribe scripts filled by LillyDirect, Eli Lilly’s direct-to-consumer platform.
معلومات السوق الآنية عبر فئات الأصول
Chart context, AI evidence, sentiment, related news, and verified outcome history are grouped into one asset dossier.
| المطلع | المنصب | التاريخ | النوع | القيمة |
|---|---|---|---|---|
| Pendarvis Christiane | Former Director | Jul 22 '26 | Proposed Sale | 113278,0 |
| Okupe Oluyemi | Chief Financial … | Jul 17 '26 | Option Exercise | 35887,0 |
| Okupe Oluyemi | Chief Financial … | Jul 17 '26 | Sale | 229168,0 |
| Okupe Oluyemi | Chief Financial … | Jul 06 '26 | Option Exercise | 35887,0 |
| Okupe Oluyemi | Chief Financial … | Jul 06 '26 | Sale | 261351,0 |
| Oluyemi Okupe | Officer | Jul 06 '26 | Proposed Sale | 1096799,0 |
| Carroll Patrick Harrison | Chief Medical … | Jun 18 '26 | Sale | 830410,0 |
| Okupe Oluyemi | Chief Financial … | Jun 22 '26 | Option Exercise | 31944,0 |
| Okupe Oluyemi | Chief Financial … | Jun 22 '26 | Sale | 619217,0 |
| Carroll Patrick Harrison | Officer | Jun 18 '26 | Proposed Sale | 830410,0 |
المصدر: FinViz — قد تكون البيانات متأخرة
أخبار منتقاة بالذكاء الاصطناعي تؤثر على سعر HIMS والمشاعر والاتجاه
Hims & Hers Health will allow providers to prescribe scripts filled by LillyDirect, Eli Lilly’s direct-to-consumer platform.
Telehealth investors weigh Amazon’s new anti-obesity drug push against this platform’s recent rapid growth, today, April 21, 2026.
Michigan-based investment advisor Cedar Grove Capital Management recently released its first quarter 2026 investor letter. A copy of the letter …
On April 16, 2026, investors monitored an FDA peptide review that could be a boost to Hims & Hers Health.
Hims may have an chance to grow peptides business as a potential revenue driver, with FDA review in 2026 shaping …
Market Catalysts Host Julie Hyman and Yahoo Finance Senior Reporter Brooke DiPalma track several of the day's top trending stock …
تحليل متعدد المزودين بالذكاء الاصطناعي